Physician

Oswald Lightsey Mikell, M.D.

According to 2025 Medicare claims, Oswald Mikell, M.D. (NPI: 1669414819) practices dermatology in the Hilton Head Island-Bluffton-Port Royal, SC market, with the plurality of this provider's patient population coming from Beaufort, SC. This provider's primary affiliated billing organization is HERITAGE DERMATOLOGY PC (NPI: 1427087089; TIN: 57-0924507) and primary practice location at 29909-7511.

Mikell's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 949 traditional Medicare patients, billed 6,742 HCPCS/CPT codes, and received $720,696 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 573 prescription claims across 305 beneficiaries totaling $229,923 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 23 records totaling $684. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,046,757 to $720,696. Similarly, Part D prescription costs have fallen sharply in recent years, from $433,191 to $229,923. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,132	16,468	$1,046,757
2016	2,180	17,503	$1,015,477
2017	2,032	16,345	$950,195
2018	1,609	13,013	$795,085
2019	1,600	11,651	$785,805
2020	1,722	12,578	$772,420
2021	1,344	8,600	$690,223
2022	1,038	7,426	$610,874
2023	929	6,762	$563,204
2024	949	6,742	$720,696

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	563	1,119	$433,191
2016	611	1,175	$377,249
2017	658	1,264	$497,610
2018	759	1,636	$604,500
2019	802	1,695	$626,770
2020	544	1,166	$518,877
2021	403	763	$286,538
2022	272	543	$214,007
2023	271	590	$311,719
2024	305	573	$229,923

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	424	565	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	574	814	$58
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	251	308	$36
17000	Destruction of precancer skin growth, 1 growth	367	500	$27
17003	Destruction of precancer skin growth, 2-14 growths	287	2,047	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	14	392	$100,798
Clobetasol Propionate	Clobetasol Propionate	56	1,740	$2,086
Triamcinolone Acetonide	Triamcinolone Acetonide	122	3,583	$1,459
Doxycycline Hyclate	Doxycycline Hyclate	60	1,683	$1,113
Metronidazole	Metronidazole	13	440	$962

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$684	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Oswald Lightsey Mikell, M.D.?

Tedicare shows public-source Medicare data for Oswald Lightsey Mikell, M.D. (NPI 1669414819), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Oswald Lightsey Mikell, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Oswald Lightsey Mikell, M.D.?

Oswald Lightsey Mikell, M.D. is linked to HERITAGE DERMATOLOGY PC (billing NPI 1427087089) in the available physician profile data.

Does Oswald Lightsey Mikell, M.D. have Open Payments data?

Oswald Lightsey Mikell, M.D. has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.